Drug Shortage Report for L-ARGININE HYDROCHLORIDE INJECTION
| Report ID | 188188 |
| Drug Identification Number | 00399736 |
| Brand name | L-ARGININE HYDROCHLORIDE INJECTION |
| Common or Proper name | L-ARGININE HYDROCHLORIDE INJECTION |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | ARGININE HYDROCHLORIDE |
| Strength(s) | 250MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 30 ML 1LIVI |
| ATC code | V04CD |
| ATC description | OTHER DIAGNOSTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-03-28 |
| Estimated end date | 2024-02-16 |
| Actual end date | 2024-02-06 |
| Shortage status | Resolved |
| Updated date | 2024-02-07 |
| Company comments | Baxter item: 1060 Product is available on allocation based on 100% of historical volumes |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-03-28 | French | Compare |
| v1 | 2023-03-28 | English | Compare |